Davide Sartini

3.2k total citations
87 papers, 2.5k citations indexed

About

Davide Sartini is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry. According to data from OpenAlex, Davide Sartini has authored 87 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 25 papers in Oncology and 12 papers in Clinical Biochemistry. Recurrent topics in Davide Sartini's work include Biochemical and Molecular Research (19 papers), RNA modifications and cancer (18 papers) and Paraoxonase enzyme and polymorphisms (11 papers). Davide Sartini is often cited by papers focused on Biochemical and Molecular Research (19 papers), RNA modifications and cancer (18 papers) and Paraoxonase enzyme and polymorphisms (11 papers). Davide Sartini collaborates with scholars based in Italy, Netherlands and United States. Davide Sartini's co-authors include Monica Emanuelli, Valentina Pozzi, Roberto Campagna, Andrea Santarelli, Lorenzo Lo Muzio, Corrado Rubini, Monia Cecati, Eleonora Salvolini, Annamaria Offidani and Stefano Morganti and has published in prestigious journals such as Blood, PLoS ONE and Nature Cell Biology.

In The Last Decade

Davide Sartini

84 papers receiving 2.4k citations

Peers

Davide Sartini
Davide Sartini
Citations per year, relative to Davide Sartini Davide Sartini (= 1×) peers Osamu Wada‐Hiraike

Countries citing papers authored by Davide Sartini

Since Specialization
Citations

This map shows the geographic impact of Davide Sartini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Sartini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Sartini more than expected).

Fields of papers citing papers by Davide Sartini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Sartini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Sartini. The network helps show where Davide Sartini may publish in the future.

Co-authorship network of co-authors of Davide Sartini

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Sartini. A scholar is included among the top collaborators of Davide Sartini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Sartini. Davide Sartini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pozzi, Valentina, Alice Romagnoli, Giovanni Tossetta, et al.. (2026). Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology. Journal of Xenobiotics. 16(1). 9–9.
2.
Belloni, Alessia, Roberto Campagna, Valentina Notarstefano, et al.. (2025). Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 330. 125726–125726. 9 indexed citations
3.
Pozzi, Valentina, Elisa Molinelli, Roberto Campagna, et al.. (2024). Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro. Human Cell. 37(3). 729–738. 5 indexed citations
4.
Emanuelli, Monica, Roberto Campagna, Monia Cecati, et al.. (2024). Paraoxonase‐2 shRNA‐mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines. Journal of Cellular Biochemistry. 125(7). e30572–e30572. 6 indexed citations
5.
Campagna, Roberto, Eleonora Salvolini, Monia Cecati, et al.. (2024). Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes. Biomolecules. 14(2). 208–208. 9 indexed citations
6.
Sartini, Davide, Roberto Campagna, Valentina Pozzi, et al.. (2024). Targeting nicotinamide N‐methyltransferase decreased aggressiveness of osteosarcoma cells. European Journal of Clinical Investigation. 54(6). e14185–e14185. 7 indexed citations
7.
Memè, Lucia, Fabrizio Bambini, G Gallusi, et al.. (2023). The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study. Applied Sciences. 13(3). 1625–1625. 7 indexed citations
8.
Campagna, Roberto, Alessia Belloni, Valentina Pozzi, et al.. (2022). Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines. International Journal of Molecular Sciences. 24(1). 338–338. 26 indexed citations
9.
Memè, Lucia, Davide Sartini, Valentina Pozzi, et al.. (2022). Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study. Materials. 15(20). 7250–7250. 15 indexed citations
10.
Gao, Yongzhi, Matthijs J. van Haren, Paolo Innocenti, et al.. (2021). Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics. Journal of Medicinal Chemistry. 64(17). 12938–12963. 54 indexed citations
11.
Togni, Lucrezia, Marco Mascitti, Arianna Vignini, et al.. (2021). Treatment-Related Dysgeusia in Oral and Oropharyngeal Cancer: A Comprehensive Review. Nutrients. 13(10). 3325–3325. 33 indexed citations
12.
Haren, Matthijs J. van, Yurui Zhang, Yongzhi Gao, et al.. (2021). Macrocyclic peptides as allosteric inhibitors of nicotinamide N -methyltransferase (NNMT). RSC Chemical Biology. 2(5). 1546–1555. 49 indexed citations
13.
Haren, Matthijs J. van, Yongzhi Gao, Roberto Campagna, et al.. (2021). Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity. Biomolecules. 11(9). 1357–1357. 36 indexed citations
14.
Sartini, Davide, Guendalina Lucarini, Corrado Rubini, et al.. (2019). Differential expression of nicotinamide N‐methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study. Journal of the European Academy of Dermatology and Venereology. 34(3). e121–e123. 2 indexed citations
15.
Salvolini, Eleonora, Corrado Rubini, Guendalina Lucarini, et al.. (2019). Nicotinamide N‐methyltransferase in nonmelanoma skin cancers. European Journal of Clinical Investigation. 49(12). e13175–e13175. 18 indexed citations
16.
Mascitti, Marco, Roberto Campagna, Davide Sartini, et al.. (2018). Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation. Clinical Oral Investigations. 23(2). 829–838. 33 indexed citations
17.
Cecati, Monia, Davide Sartini, Valentina Pozzi, et al.. (2012). Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). The Journal of Maternal-Fetal & Neonatal Medicine. 26(1). 26–31. 5 indexed citations
18.
Poloni, Antonella, Davide Sartini, Monica Emanuelli, et al.. (2011). Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. Cytokine. 53(3). 376–383. 10 indexed citations
19.
Emanuelli, Monica, et al.. (2007). Placental Overexpression of Transforming Growth Factor-β3 in the HELLP Syndrome. Gynecologic and Obstetric Investigation. 65(1). 1–5. 5 indexed citations
20.
Muzio, Lorenzo Lo, Andrea Santarelli, Monica Emanuelli, et al.. (2006). Genetic Analysis of Oral Squamous Cell Carcinoma by cDNA Microarrays Focused Apoptotic Pathway. International Journal of Immunopathology and Pharmacology. 19(3). 675–682. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026